CUSIP: 315918466
What is CUSIP 315918466?
CUSIP 315918466 identifies 315918466 - Fidelity Adv Biotech Inst - MF in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP 315918466:
As of 31 Dec 2025, 1 institutional investors reported holding 19,965 shares of Fidelity Adv Biotech Inst - MF.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 19,965 | $824,000 | -$24,769 | $41.27 | 1 |
| 2025 Q3 | 20,679 | $754,568 | +$754,568 | $36.49 | 2 |
| 2025 Q2 | 0 | $0 | -$588,310 | $41.27 | 0 |
| 2025 Q1 | 20,679 | $588,310 | +$27,903 | $28.45 | 2 |
| 2024 Q4 | 19,698 | $588,575 | +$30,926 | $29.88 | 1 |
| 2024 Q3 | 18,663 | $683,081 | $36.60 | 1 | |
| 2024 Q2 | 18,663 | $611,040 | $32.74 | 1 | |
| 2024 Q1 | 18,663 | $631,000 | -$30,675 | $33.81 | 1 |
| 2023 Q4 | 19,690 | $587,964 | +$323,953 | $29.86 | 2 |
| 2023 Q3 | 9,044 | $233,336 | +$233,336 | $25.80 | 1 |
| 2023 Q1 | 0 | $0 | -$729,000 | $41.27 | 0 |
| 2022 Q4 | 26,692 | $729,000 | $27.31 | 1 | |
| 2022 Q3 | 26,692 | $681,000 | $25.51 | 1 | |
| 2022 Q2 | 26,692 | $624,000 | $23.38 | 1 | |
| 2022 Q1 | 26,692 | $724,000 | $27.12 | 1 | |
| 2021 Q4 | 26,692 | $790,000 | +$123,656 | $29.60 | 1 |
| 2021 Q3 | 22,514 | $813,000 | +$3,033 | $36.11 | 1 |
| 2021 Q2 | 22,430 | $803,000 | $35.80 | 1 | |
| 2021 Q1 | 22,430 | $788,000 | $35.13 | 1 | |
| 2020 Q4 | 22,430 | $817,000 | +$59,955 | $36.42 | 1 |
| 2020 Q3 | 20,784 | $710,000 | $34.16 | 1 | |
| 2020 Q2 | 20,784 | $713,000 | $34.31 | 1 | |
| 2020 Q1 | 20,784 | $547,000 | $26.32 | 1 | |
| 2019 Q4 | 20,784 | $616,000 | +$37,196 | $29.64 | 1 |
| 2019 Q3 | 19,529 | $504,000 | $25.81 | 1 | |
| 2019 Q2 | 19,529 | $550,000 | $28.16 | 1 | |
| 2019 Q1 | 19,529 | $559,000 | $28.62 | 1 | |
| 2018 Q4 | 19,529 | $489,000 | +$489,000 | $25.04 | 1 |
| 2016 Q3 | 0 | $0 | -$44,033,000 | $41.27 | 0 |
| 2016 Q2 | 2,179 | $44,033,000 | +$4,385,113 | $20207.89 | 1 |
| 2015 Q4 | 1,962 | $53,885,000 | +$53,885,000 | $27464.32 | 1 |
| 2015 Q3 | 0 | $0 | -$1,251,857 | $41.27 | 0 |
| 2015 Q2 | 60,243 | $1,251,857 | +$585,896 | $20.78 | 1 |
| 2015 Q1 | 32,048 | $951,000 | -$309,473 | $29.67 | 1 |
| 2014 Q4 | 42,477 | $1,098,459 | -$314,795 | $25.86 | 1 |
| 2014 Q3 | 54,650 | $1,270,623 | -$222,086 | $23.25 | 1 |
| 2014 Q2 | 64,202 | $1,386,771 | +$85,515 | $21.60 | 1 |
| 2014 Q1 | 60,243 | $1,251,857 | -$2,160,453 | $20.78 | 1 |